Aquinox to buy biopharmaceutical firm Neoleukin Therapeutics

This article was originally published here

Neoleukin is involved in the creation of next-generation immunotherapies using de novo protein design technology. The company applies advanced computational methods for the designing of proteins, which show

The post Aquinox to buy biopharmaceutical firm Neoleukin Therapeutics appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply